The company's purpose is to manufacture and trade in ophthalmic instruments of all kinds and related products. Furthermore, the company aims to finance research and development and to exploit patents, intellectual property rights and other rights in the field of medical technology. The company may establish branches and subsidiaries in Switzerland and abroad and participate in other companies in Switzerland and abroad. The company may acquire, hold, manage, encumber, utilize and sell real estate and intellectual property rights in Switzerland and abroad, as well as finance other companies, with the exception of transactions prohibited by the Federal Act on the Acquisition of Real Estate by Persons Abroad (BewG). The company may grant secured or unsecured loans to its shareholders, direct or indirect subsidiaries, parent companies or sister companies, as well as to third parties, or provide guarantees or securities in their favor. Additionally, it may engage in cash pooling with its group companies or join such a system, including periodic account balancing. All of this may be done by the company without consideration, on preferential terms, without interest or other compensation, excluding the company's profitability and assuming cluster risks. The company may engage in all commercial, financial and other activities that appear suitable to promote the company's purpose or are related to it. In doing so, the interests and general orientation of the Alcon Group shall be taken into account, to the extent permitted by law. In pursuing its corporate purpose, the company aims to create long-term, sustainable value.